Table 1 Associations of clinical-pathological characteristics and preoperative VTE
Variable | No VTE (n = 244) | VTE (n = 57) | P value |
|---|---|---|---|
Age (year) | 76.30 ± 11.10 | 77.11 ± 9.38 | 0.764 |
Male gender | 80 (32.79) | 15 (26.32) | 0.344 |
BMI (kg/m2) | 22.91 ± 3.69 | 22.91 ± 4.09 | 0.684 |
Garden typing | Â | Â | 0.071 |
 Type III and IV | 216 (88.52) | 55 (96.49) |  |
 Type I and II | 28 (11.48) | 2 (3.51) |  |
Rockwood typing | Â | Â | 0.280 |
 Subcapital | 186 (77.82) | 47 (87.04) |  |
 Transcervical | 40 (16.74) | 6 (11.11) |  |
 Basicervical | 13 (5.44) | 1 (1.85) |  |
Bed rest time > 3 days | 120 (49.38) | 34 (59.65) | 0.163 |
Bed rest time > 7 days | 54 (22.22) | 20 (35.00) | 0.043 |
Bed rest time > 14 days | 30 (12.35) | 15 (26.32) | 0.008 |
Smoking | 20 (8.20) | 7 (12.28) | 0.331 |
Comorbidity | |||
 Hypertension | 144 (59.02) | 27 (47.37) | 0.110 |
 Diabetes | 71 (29.10) | 10 (17.54) | 0.077 |
 Malignancy | 30 (12.30) | 7 (12.28) | 0.998 |
 Ischemic heart disease | 57 (23.36) | 8 (14.04) | 0.123 |
 Atrial fibrillation | 19 (7.79) | 5 (8.77) | 1.000 |
 Cerebrovascular disorder | 44 (18.03) | 6 (10.53) | 0.170 |
 Chronic kidney disease | 12 (4.92) | 3 (5.26) | 1.000 |
 Chronic pulmonary disease | 10 (4.10) | 3 (5.26) | 0.978 |
 Autoimmune disease | 11 (4.51) | 3 (5.26) | 1.000 |
 Movement disorder | 18 (7.38) | 14 (24.56) | < 0.001 |
 Alzheimer's disease | 7 (2.87) | 4 (7.02) | 0.267 |
 Multiple fractures | 6 (2.46) | 7 (12.28) | 0.003 |
Concomitant medication | |||
 Steroid or immunosuppressant | 14 (5.74) | 2 (3.51) | 0.728 |
 Antiplatelet drug | 66 (27.05) | 8 (14.04) | 0.040 |
Prophylactic anticoagulation | 137 (56.85) | 25 (43.86) | 0.077 |
D-dimer (μg/mL) | 10.11 ± 17.27 | 11.35 ± 22.88 | 0.067 |
Fbg (g/L) | 3.92 ± 1.11 | 4.2 ± 1.28 | 0.035 |
ESR (mm/h) | 37.35 ± 26.85 | 45.33 ± 25.97 | 0.035 |
hsCRP (mg/L) | 42.84 ± 36.21 | 54.63 ± 48.69 | 0.142 |